{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:14:34Z","timestamp":1783991674320,"version":"3.55.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Frontiers in Neuroendocrinology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.yfrne.2025.101204","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:13:10Z","timestamp":1751422390000},"page":"101204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The role of the stress adaptive response in multiple sclerosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Evangelia","family":"Zapanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Dermentzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Kazakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kilindireas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s42000-020-00197-8","article-title":"Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications","volume":"19","author":"Anagnostouli","year":"2020","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.yfrne.2025.101204_b0055","unstructured":"Antoniou-Tsigkos A., et al. 2019. Adrenal androgens, in: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000."},{"key":"10.1016\/j.yfrne.2025.101204_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1586\/14737175.2013.865866","article-title":"Environmental factors in multiple sclerosis","volume":"13","author":"Ascherio","year":"2013","journal-title":"Expert Rev. Neurother."},{"issue":"11","key":"10.1016\/j.yfrne.2025.101204_b0075","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1046\/j.1365-2826.2003.01099.x","article-title":"Corticotropin-releasing hormone immunoreactivity in human T and Bcells and macrophages: colocalization with arginine vasopressin","volume":"15","author":"Baker","year":"2003","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.55782\/ane-2007-1655","article-title":"Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration","volume":"67","author":"Ba\u0142kowiec-Iskra","year":"2007","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"issue":"10","key":"10.1016\/j.yfrne.2025.101204_b0435","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.it.2004.08.005","article-title":"More sympathy for autoimmunity with neuropeptide Y?","volume":"25","author":"Bedoui","year":"2004","journal-title":"Trends Immunol."},{"issue":"1805","key":"10.1016\/j.yfrne.2025.101204_b0110","article-title":"Regulation of dopamine system responsivity and its adaptive and pathological response to stress","volume":"282","author":"Belujon","year":"2015","journal-title":"Proc. Biol. Sci."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00441-017-2649-1","article-title":"Locus coeruleus","volume":"373","author":"Benarroch","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"7198","key":"10.1016\/j.yfrne.2025.101204_b0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.yfrne.2025.101204_b0065","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4103\/1673-5374.310608","article-title":"Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases","volume":"16","author":"Bhuiyan","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.yfrne.2025.101204_b0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46797","article-title":"The effects of psychosocial stress on dopaminergic function and the acute stress response","volume":"8","author":"Bloomfield","year":"2019","journal-title":"Elife"},{"issue":"21","key":"10.1016\/j.yfrne.2025.101204_b0350","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1093\/hmg\/ddq328","article-title":"Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals","volume":"19","author":"Briggs","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1191\/1352458506ms1296oa","article-title":"Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships","volume":"12","author":"Brown","year":"2006","journal-title":"Mult. Scler."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imlet.2013.12.020","article-title":"CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes","volume":"158","author":"Camperio","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.yfrne.2025.101204_b0005","series-title":"Bodily changes in pain, hunger, fear and rage: an account of recent researches into the function of emotional excitement","author":"Cannon","year":"1929"},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0450","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1038\/s41598-017-10173-9","article-title":"Role of dopamine D2 receptor in stress-induced myelin loss","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.yfrne.2025.101204_b0255","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic\u2013pituitary\u2013adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.yfrne.2025.101204_b0370","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","article-title":"Stress and disorders of the stress system","volume":"5","author":"Chrousos","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.yfrne.2025.101204_b0020","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","article-title":"The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis","volume":"267","author":"Chrousos","year":"1992","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0490","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","article-title":"Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop","volume":"109","author":"Cosentino","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11481-012-9410-z","article-title":"Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?","volume":"8","author":"Cosentino","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0470","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0165-5728(02)00372-7","article-title":"Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis","volume":"133","author":"Cosentino","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.yfrne.2025.101204_b0485","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000336981","article-title":"Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-\u03b2 therapy","volume":"19","author":"Cosentino","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.yfrne.2025.101204_b0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fncel.2014.00362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"da Fonseca","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0430","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2003.10.012","article-title":"Astrocytic beta2-adrenergic receptors and multiple sclerosis","volume":"15","author":"De Keyser","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0335","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2004.02.009","article-title":"Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production","volume":"151","author":"DeRijk","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12967-020-02276-1","article-title":"Integrative systems and functional analyses reveal a role of dopaminergic signaling in myelin pathogenesis","volume":"18","author":"Ding","year":"2020","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.yfrne.2025.101204_b0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1043-2760(99)00188-5","article-title":"Stress hormones, Th1\/Th2 patterns, pro\/anti-inflammatory cytokines and susceptibility to disease","volume":"10","author":"Elenkov","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0375","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2013an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(95)00098-M","article-title":"Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis","volume":"62","author":"Erkut","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress","volume":"303","author":"Esposito","year":"2002","journal-title":"J Pharmacol. Exp."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"Euler","year":"1931","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0390","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.2000.279.4.L675","article-title":"beta-adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the IkappaB\/NF-kappaB pathway","volume":"279","author":"Farmer","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b9000","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archneur.55.1.66","article-title":"Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation","volume":"55","author":"Fassbender","year":"1998","journal-title":"Arch Neurol."},{"key":"10.1016\/j.yfrne.2025.101204_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(92)91545-P","article-title":"Neonatal lesions of the ventral tegmental area affect monoaminergic responses to stress in the medial prefrontal cortex and other dopamine projection areas in adulthood","volume":"596","author":"Feenstra","year":"1992","journal-title":"Brain Res."},{"issue":"Suppl 2","key":"10.1016\/j.yfrne.2025.101204_b0360","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.13447","article-title":"Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system","volume":"139","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"issue":"Pt 1","key":"10.1016\/j.yfrne.2025.101204_b0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/brain\/awh002","article-title":"Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis","volume":"127","author":"Gadea","year":"2004","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","article-title":"Role of the innate immune system in the pathogenesis of multiple sclerosis","volume":"221","author":"Gandhi","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"10258","key":"10.1016\/j.yfrne.2025.101204_b0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.yfrne.2025.101204_b0090","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2005.09.010","article-title":"The role of stress-response systems for the pathogenesis and progression of MS","volume":"26","author":"Gold","year":"2005","journal-title":"Trends Immunol."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0330","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.04.014","article-title":"Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis","volume":"165","author":"Gold","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13760-012-0061-x","article-title":"Self-tolerance in multiple sclerosis","volume":"112","author":"Gonsette","year":"2012","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0029-1211419","article-title":"Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis","volume":"104","author":"Grasser","year":"1996","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0240","first-page":"1394","article-title":"Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress","volume":"130","author":"Harbuz","year":"1992","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0425","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-5728(02)00322-3","article-title":"Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls","volume":"132","author":"Heesen","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0290","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.psyneuen.2007.05.002","article-title":"Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis \u2013 a review","volume":"32","author":"Heesen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0285","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbi.2010.04.003","article-title":"Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesis","volume":"24","author":"Heidbrink","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2008.06.008","article-title":"The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity","volume":"29","author":"Hermann-Kleiter","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-015-4151-3","article-title":"Ventral tegmental area dopamine revisited: effects of acute and repeated stress","volume":"233","author":"Holly","year":"2016","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood-brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.10766","article-title":"Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions","volume":"55","author":"Huitinga","year":"2004","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.yfrne.2025.101204_b0185","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/j.febslet.2011.04.006","article-title":"Environmental triggers of multiple sclerosis","volume":"585","author":"Kakalacheva","year":"2011","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.40.2.229","article-title":"Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement","volume":"40","author":"Kermode","year":"1990","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.yfrne.2025.101204_b0420","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archneurol.2010.222","article-title":"A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis","volume":"67","author":"Khoury","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yfrne.2025.101204_b0465","series-title":"Nerve-Driven-Immunity \u2013 Neurotransmitters and Neuropeptides in the Immune System","first-page":"1","article-title":"Dopamine in the immune system: dopamine receptors in immune cells, potent effects, endogenous production and involvement in immune and neuropsychiatric diseases","author":"Levite","year":"2012"},{"issue":"5","key":"10.1016\/j.yfrne.2025.101204_b0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-016-1640-4","article-title":"Dopamine, T cells and multiple sclerosis (MS)","volume":"124","author":"Levite","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"5","key":"10.1016\/j.yfrne.2025.101204_b0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1034\/j.1600-0404.2002.01155.x","article-title":"Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment","volume":"105","author":"Limone","year":"2002","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000226428","article-title":"Relationship between psychosocial factors and onset of multiple sclerosis","volume":"62","author":"Liu","year":"2009","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200216010-00001","article-title":"Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol)","volume":"16","author":"Makhlouf","year":"2002","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0070","first-page":"1690","article-title":"Recombinant interleukin-6 activates the hypothalamic-pituitary \u2013adrenal axis in humans","volume":"77","author":"Mastorakos","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0250","first-page":"934","article-title":"Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion","volume":"79","author":"Mastorakos","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40478-019-0705-7","article-title":"Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis","volume":"7","author":"Melief","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.yfrne.2025.101204_b0275","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/glia.22562","article-title":"Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed","volume":"61","author":"Melief","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0245","first-page":"848","article-title":"Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function","volume":"79","author":"Michelson","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.yfrne.2025.101204_b0195","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eurpsy.2008.06.003","article-title":"The impact of stressful life events on risk of relapse in women with multiple sclerosis: a prospective study","volume":"23","author":"Mitsonis","year":"2008","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.55.1.55","article-title":"Psychological stress and the subsequent appearance of new brain MRI lesions in MS","volume":"55","author":"Mohr","year":"2000","journal-title":"Neurology"},{"issue":"7442","key":"10.1016\/j.yfrne.2025.101204_b0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.38041.724421.55","article-title":"Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis","volume":"328","author":"Mohr","year":"2004","journal-title":"BMJ"},{"issue":"6871","key":"10.1016\/j.yfrne.2025.101204_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.yfrne.2025.101204_b0030","unstructured":"Nezi M., et al., 2015. Corticotropin Releasing Hormone And The Immune\/Inflammatory Response in: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000362736","article-title":"Stress, the stress system and the role of glucocorticoids","volume":"22","author":"Nikolaides","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.yfrne.2025.101204_b0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-12-95","article-title":"TH1\/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab","volume":"12","author":"Oreja-Guevara","year":"2012","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0460","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pscychresns.2014.06.001","article-title":"Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study","volume":"223","author":"Ozcelik-Eroglu","year":"2014","journal-title":"Psychiatry Res."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","article-title":"Role of dopamine in the physiology of T-cells and dendritic cells","volume":"216","author":"Pacheco","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"Pt 3","key":"10.1016\/j.yfrne.2025.101204_b0355","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awq362","article-title":"Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"134","author":"Polak","year":"2011","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.yfrne.2025.101204_b0500","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.1103096","article-title":"Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity","volume":"188","author":"Prado","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.yfrne.2025.101204_b0050","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","article-title":"Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride","volume":"24","author":"Pruessner","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1515\/revneuro-2018-0002","article-title":"Multiple sclerosis pathogenesis: missing pieces of an old puzzle","volume":"30","author":"Rahmanzadeh","year":"2018","journal-title":"Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.yfrne.2025.101204_b0345","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28518","article-title":"Associations between maternal antenatal corticosteroid treatment and psychological developmental and neurosensory disorders in children","volume":"5","author":"R\u00e4ikk\u00f6nen","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"Ramagopalan","year":"2009","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.yfrne.2025.101204_b0295","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.37.5.849","article-title":"Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy","volume":"37","author":"Reder","year":"1987","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.410330309","article-title":"A population-based study of multiple sclerosis in twins: update","volume":"33","author":"Sadovnick","year":"1993","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000049004","article-title":"Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism","volume":"9","author":"Saha","year":"2001","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.yfrne.2025.101204_b0340","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1523\/JNEUROSCI.05-05-01222.1985","article-title":"Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging","volume":"5","author":"Sapolsky","year":"1985","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0315","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/MCB.15.2.943","article-title":"Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors","volume":"15","author":"Scheinman","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ana.10187","article-title":"Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume","volume":"51","author":"Schumann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yfrne.2025.101204_b0015","doi-asserted-by":"crossref","unstructured":"Selye H., 1976. Psychopathology of Human Adaptation in: Stress without Distres, pp 137-146.","DOI":"10.1007\/978-1-4684-2238-2_9"},{"issue":"8","key":"10.1016\/j.yfrne.2025.101204_b0270","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1210\/endo.142.8.8292","article-title":"Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone","volume":"142","author":"Stefferl","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.yfrne.2025.101204_b0325","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/WNL.53.4.772","article-title":"Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS","volume":"53","author":"Then","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0220","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.clinthera.2020.05.002","article-title":"Effect of stress on neuroimmune processes","volume":"42","author":"Theoharides","year":"2020","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects","volume":"139","author":"Theoharides","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.yfrne.2025.101204_b0100","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1523\/JNEUROSCI.2808-11.2011","article-title":"Antipsychotic drugs rapidly induce dopamine neurondepolarization block in a developmental rat model of schizophrenia","volume":"31","author":"Valenti","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0495","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","article-title":"Disturbed regulatory T cell homeostasis in multiple sclerosis","volume":"16","author":"Venken","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2025.101204_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2007.09.006","article-title":"Stress hormones and immune function","volume":"252","author":"Webster Marketon","year":"2008","journal-title":"Cell. Immunol."},{"issue":"Pt 6","key":"10.1016\/j.yfrne.2025.101204_b0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/120.6.1067","article-title":"The neuroendocrine axis in patients with multiple sclerosis","volume":"120","author":"Wei","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.yfrne.2025.101204_b0035","unstructured":"What is MS\/Definition of MS., 2024. https:\/\/www.nationalmssociety.org\/understanding-ms\/what-is-ms. 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935."},{"issue":"3","key":"10.1016\/j.yfrne.2025.101204_b0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WCO.0000000000000205","article-title":"Advances in the immunopathogenesis of multiple sclerosis","volume":"28","author":"Yadav","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.yfrne.2025.101204_b0475","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.08.015","article-title":"Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis","volume":"214","author":"Zaffaroni","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.yfrne.2025.101204_b0455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Zhang","year":"2012","journal-title":"Schizophr. Res."},{"issue":"Pt 2","key":"10.1016\/j.yfrne.2025.101204_b0410","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/brain\/117.2.307","article-title":"Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis","volume":"117","author":"Zoukos","year":"1994","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.yfrne.2025.101204_b0405","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.410310614","article-title":"beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1","volume":"31","author":"Zoukos","year":"1992","journal-title":"Ann. Neurol."}],"container-title":["Frontiers in Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302225000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302225000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:27:05Z","timestamp":1778473625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091302225000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":100,"alternative-id":["S0091302225000305"],"URL":"https:\/\/doi.org\/10.1016\/j.yfrne.2025.101204","relation":{},"ISSN":["0091-3022"],"issn-type":[{"value":"0091-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the stress adaptive response in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Frontiers in Neuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yfrne.2025.101204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101204"}}